[1]
Serša, G. 2023. Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report. Radiology and Oncology. 57, 2 (Jun. 2023), 141–149.